RedShiftBio
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
131 Middlesex Tpke, Burlington, Massachu...Phone Number
(781) 345-7308Website
www.redshiftbio.comRevenue
$7.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About RedShiftBio
RedShiftBio® is a provider of innovative analytical instrumentation for the research, development and manufacture of protein therapeutic drugs. The company has developed a powerful new analytical technique, Microfluidic Modulation Spectroscopy (MMS) that enables direct probing of the biophysical structure of proteins. The patented MMS technology provides comprehensive secondary structure information across five key measurements, in a single automated analysis, replacing the requirement to run samples on multiple instruments.Explore more
RedShiftBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RedShiftBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if RedShiftBio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on RedShiftBio recently announced quarterly report
RedShiftBio, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once RedShiftBio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if RedShiftBio had a recent Job posting/layoffs
Check if RedShiftBio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when RedShiftBio launches new products
Congratulate Masked Content for being promoted to Masked Content at RedShiftBio
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to RedShiftBio
Compare insights from companies similar to RedShiftBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RedShiftBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RedShiftBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RedShiftBio.
RedShiftBio financials insights
Gather financial insights about RedShiftBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Series B
$6.2M
2012
Private Equity
$2.4M
2014
Private Equity
$751K
2015
Private Equity
$1M
2017
Series C
$11M
2020
Series D
$18M
Debt
$350K
2021
Series E
$20M
RedShiftBio Tech Stack
A closer look at the technologies used by RedShiftBio
Most Recent Scoops
Project
, according to a mid-level source in application management, is in the midst of initiatives related to user experience. The organization is currently evaluating various vendors.
User Experience
Project
, according to a mid-level source in application management, is in the midst of initiatives related to email.
Email, Messaging
Project
, according to a mid-level source in application management, is in the midst of initiatives related to sales execution. The organization is currently evaluating various vendors.
Sales, Sales Development
Project
, according to a mid-level source in application management, is in the midst of initiatives related to customer relationship management (CRM).
CRM
Project
Retail/Store Systems
RedShiftBio News & Media
Tom O'Lenic joins RedShiftBio as Chief Executive Officer
Extensive Commercial Expertise and Proven Track Record of Success Tom O'Lenic's appointment marks a strategic move for RedShiftBio amidst rising opportunities in biophysical characterization and bioprocess analytics markets. BOXBOROUGH, Mass., March 7, 2024 /PRNewswire/ -- RedShift...RedShift BioAnalytics Announces Distribution Agreement with Flownamics for The Director™ Liquid Handler.
The recently launched HaLCon Analyzer from RedShiftBio and the Flownamics Director are perfectly suited to jointly deliver HPLC-quality protein titer for bioprocessing with even greater efficiency and throughput. BOXBOROUGH, Mass., Aug. 24, 2023 /PRNewswire/ -- RedShift BioAnalytics...RedShift BioAnalytics Announces Launch of Aurora Second-Generation MMS Platform, for Ultra-Sensitive Biophysical Characterization of Biomolecules
Aurora, powered by RedShift BioAnalytics' proprietary MMS technology, delivers a 10-fold decrease in sample volume at a lower price point than the first generation AQS3 Pro and Apollo instruments, making novel MMS measurements available to more researchers and applications than ever...RedShift BioAnalytics Launches HaLCon™ Analyzer, Providing Simple and Accurate On-Demand Protein Titer Measurements for Bioprocess Development and Manufacturing
RedShiftBio introduces the HaLCon Protein Analyzer, the first fit-for-purpose liquid chromatography (LC) system designed specifically to provide quick, easy, and accurate protein titer measurements for biopharmaceutical development and manufacturing. BOXBOROUGH, Mass. , June 7, 2023...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RedShiftBio
Sign Up For FreeTo access detailed company insights
RedShiftBio® is a provider of innovative analytical instrumentation for the research, development and manufacture of protein therapeutic drugs. The company has developed a powerful new analytical technique, Microfluidic Modulation Spectroscopy (MMS) that enables direct probing of the biophysical structure of proteins. The patented MMS technology pr... Read More
